semaglutide cardiovascular outcomes news Effects of on mortality, cardiovascular, and kidney across the cardio-kidney-metabolic continuum: a systematic review and meta-analysis | Diabetology #VisualAbstract: Semaglutide and Cardiovascular Outcomes

To further validate the in vitro findings, an STZ-induced T2DM model in rats was established, and RYGB surgery was performed on T2DM rats, or T2DM rats were alternatively treated with GLP-1R agonist EX-4 and examined glucose metabolism- and lipid metabolism-related indicators were examined

arXiv Systematic Reviews / Meta-analyses A recent systematic review on type 3 diabetes draws together evidence of overlapping mechanistic pathways, supporting the idea that agents targeting insulin resistance (including GLP-1 RAs) might have benefit

Antimicrobial peptides: classification, design, application and research progress in multiple fields

All results were analyzed using the t -test, one-way ANOVA, and two-way ANOVA as appropriate

RET gene fusions in malignancies of the thyroid and other tissues

Beware of unregulated sources selling GLP-1 without a prescription these products may be counterfeit and dangerous